Bahraini Surgeon Presents Revolutionary ICG-Guided Breast Surgery Technique at Prestigious ACS Congress UAE 2025
The innovative approach, which represents the first clinical application of ICG dye specifically for benign breast nodule like fibroadenoma visualization, demonstrated remarkable results in a clinical series of female patients in Moscow at University Hospital no.1, achieving 100% successful excision rates with enhanced cosmetic outcomes and no postoperative complications.
"This technique revolutionizes how we approach benign breast lesions," said Dr. Kameela. "By providing real-time fluorescence guidance, we can achieve unprecedented precision in tumor removal while maximizing preservation of healthy breast tissue, resulting in superior cosmetic outcomes for our patients."
The ICG-guided technique addresses longstanding challenges in breast surgery by offering surgeons enhanced visualization capabilities during the procedure. The fluorescent dye, injected directly into the lesion under ultrasound guidance, allows for precise identification of tumor boundaries and confirmation of complete excision.
Key benefits of the technique include:
- Enhanced surgical precision through real-time fluorescence guidance
- Complete tumor removal with clear margins in 100% of cases
- Improved cosmetic outcomes through tissue-preserving approach
- Reduced postoperative complications
- Higher patient satisfaction scores
The presentation at the ACS Congress UAE Chapter represents a significant milestone in surgical innovation, positioning this technique for broader clinical adoption and establishing new standards for benign breast lesion like fibroadenoma treatment.Dr. Kameela's research and innovation contributes to the growing body of evidence supporting fluorescence-guided surgery applications and demonstrates the potential for this technology to transform breast surgery practice globally.
